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OBJECTIVES The purpose of this study was to provide a comprehensive review of the literature relating to
electron beam angiography (EBA), magnetic resonance angiography, and spiral computed
tomography, currently the three most promising noninvasive methods to visualize obstruc-
tions in the coronary tree.
BACKGROUND Given the high costs and invasiveness of coronary angiography, there is increased interest in
noninvasive coronary angiography, which has made great strides to become a clinically useful
tool to augment conventional coronary angiography (CCA).
METHODS MEDLINE searches were performed to include all articles related to noninvasive angiogra-
phy utilizing either magnetic resonance imaging (MRI), multi-row detector spiral computed
tomography (MDCT), and electron beam tomography (EBT). Weighted analysis was
performed to define the published sensitivity and specificity for each technique.
RESULTS Electron beam angiography (EBA) provides an overall sensitivity of 87% and specificity of
91% for the detection of obstructive coronary artery disease (CAD). Four-level MDCT data
demonstrated an overall sensitivity of 59% and specificity of 89%, with higher accuracy in two
recent studies of 16-level detector devices. Magnetic resonance angiography demonstrated
sensitivity for detection of obstructive CAD of 77% and specificity of 71%.
CONCLUSIONS Noninvasive coronary angiography is a rapidly developing technique and currently not an
alternative to CCA in all cases. All three methods are currently used clinically in certain
centers with appropriate expertise. Selective use should prove both cost-effective and provide
a safer, less-invasive method for patients to determine the need for medical versus
revascularization therapy. (J Am Coll Cardiol 2003;42:1867–78) © 2003 by the American
College of Cardiology Foundation
Over the past decade, great strides have been made in
cardiac imaging. The ability to visualize the lumen of the
coronary artery has been at the forefront of these advances.
Selective cardiac catheterization, the reference standard for
visualization of coronary artery stenoses, is an invasive
procedure with a significant cost and small-procedure-
related morbidity and mortality. An alternative, less expen-
sive, and noninvasive test for use as a diagnostic tool before
possible intervention could have a major impact on health
care practice and cost containment. Noninvasive coronary
angiography, owing to rapid coronary motion, limited
arterial size, and tortuous course, has been very challenging.
We review here the benefits, risks, and costs of invasive
angiography to that of the three noninvasive methods with
the greatest clinical experience, namely electron beam to-
mography (EBT), multi-row-detector spiral computed to-
mography (MDCT), and magnetic resonance imaging
(MRI).
ANGIOGRAPHY
Coronary angiography remains the standard for assessment
of anatomic coronary disease (1). The limitations of this
procedure include the risks (arterial puncture, iodinated
contrast, and radiation), the need for multiple staff members
including a nurse, physician, and technologists, and the
costs incurred during the procedure and the ensuing obser-
vational period. Given these potential complications, the
physician must make reasoned decisions on its use based on
the anticipated clinical benefit versus the risks and costs of
the procedure.
Risk and utilization of invasive angiography. The proce-
dure is associated with a small but definable risk. The 1999
Joint Coronary Angiography Guidelines report a total risk
of all major complications (including mortality) from coro-
nary angiography to be just 2% (2). In 1993, some 1.8
million cardiac catheterization procedures were performed
(3). From 1979 to 2000, the number of cardiac catheteriza-
tions increased 341%. The estimated utilization of cardiac
catheterizations (inpatient and outpatient) was 2 million
in the year 2000 (3).
Costs. The 1992 mean charge for cardiac catheterization
for inpatients younger than 65 years without a diagnosis of
acute myocardial infarction was $10,880, varying by state
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from a low of $6,400 in Maryland to $17,600 in California
(4). These values included all costs associated with the
procedure, including ventriculography, observation, and
physician charges. The physician fee made up 18% of the
total, averaging $2,000 and varying from $1,300 in South
Carolina to $2,550 in California (5). The average total cost
for patients hospitalized for diagnostic cardiac catheteriza-
tion increased from $11,232 in 1993 to $16,838 in 2000 (6).
It must be noted that there is often a large disparity between
charged and collected sums; however, the costs of invasive
angiography remain high. Currently, charges for noninva-
sive angiography range from $1,500 to $2,450 (including
physician interpretation charges) in different medical cen-
ters. Research on the cost-effectiveness of noninvasive cor-
onary angiography is needed before the optimal use of this
procedure in a wide range of clinical circumstances can be
determined.
Current uses. Despite cost, inconvenience, and morbidity,
coronary angiography is the only method currently available
for defining the details of the entire coronary endoluminal
vascular anatomy, and it provides the reference standard
against which other tests are compared (7). The ability to
detect obstructive and nonobstructive disease is of para-
mount importance for guiding therapy. Although coronary
lesions that reduce luminal diameter 50% are considered
hemodynamically insignificant, they are not clinically be-
nign. These lesions may progress either acutely or chroni-
cally, and patients with nonsignificant obstructions have
significantly more cardiovascular events during follow-up
than those with truly normal coronary angiograms (8).
Furthermore, cardiac angiography can also define multiple
cardiac diseases (cardiomyopathy, heart failure, valve dis-
ease, and endothelial dysfunction).
Potential role of noninvasive angiogram. Although con-
ventional coronary angiography (CCA) remains the stan-
dard of reference for determining the severity of stenosis
resulting from atherosclerosis in the coronary arteries, it is
unfortunate that at least 20% of the clinically indicated
diagnostic CCA procedures performed each year reveal no
evidence of obstructive coronary artery disease (CAD), and
therefore do not lead to further interventional procedures
(9). This problem may be twice as significant in women. A
recent report of 9,238 angiograms from five community
hospitals demonstrated that 40.4% of women referred for
angiography were found to have nonsignificant disease,
nearly twice that of men (10). Because most of the risk of
conventional angiography including stroke, MI, infection,
and bleeding, revolves around the need for arterial access,
noninvasive methods, approached by intravenous adminis-
tration of contrast (or no contrast at all), eliminate most of
the risk associated with the procedure, including postpro-
cedural observation periods, MI, stroke, bleeding, arterial
infection, and vessel dissection.
Difficulties of noninvasive angiography. Fluoroscopy, the
method used to visualize the coronary artery lumen during
angiography, has high temporal resolution, but low contrast
resolution. Thus, it requires direct enhancement of the
coronary artery blood pool to allow visualization of the
lumen. Noninvasive angiography, without direct injection of
contrast into the artery, utilizes increased spatial resolution
to overcome the problems of loss of superb contrast en-
hancement and temporal resolution. Furthermore, rapid
motion of the coronary arteries, complex and tortuous
anatomy, as well as the small size of the vessels, all make
noninvasive imaging challenging. All three techniques rely
upon three-dimensional (3D) reconstruction to assist with
visualization. The computed tomography (CT) techniques
(EBT and MDCT) rely upon superior spatial resolution and
a venous contrast injection. The venous contrast does not
provide as robust an enhancement of the coronary arteries as
does direct arterial injection, because the contrast is diluted
by mixing with the blood pool. Magnetic resonance imaging
often utilizes gadolinium, a noniodinated contrast agent, to
increase the identification of the lumen.
ELECTRON BEAM TOMOGRAPHY
Electron beam tomography with electrocardiographic
(ECG) triggering has been used for detecting and quanti-
fying coronary artery calcifications (CAC) for more than 15
years (11,12); EBT is established as the “gold standard” for
CAC detection (13). Though CAC scores correlate well
with the total atherosclerotic burden (14,15) and strongly
predict future cardiac events (16,17), the amount of CAC
does not correlate well with the stenosis severity of a given
lesion (18). Although high calcium scores impart an approx-
imate 10-fold increased risk, they do not always impart a
tight stenosis (Table 1) (19). Moreover, because plaque
burden itself is dangerous regardless of stenosis severity, use
of calcium scanning for predicting the need for angioplasty
or bypass surgery is limited.
Electron beam tomography appears well suited for imag-
ing of the coronary artery. It has a unique combination of
high temporal resolution (100 ms/slice) and spatial resolu-
tions (0.35 0.35 1.5 mm) (13), allowing visualization of
small lesions. Furthermore, ECG triggering allows image
Abbreviations and Acronyms
3D  three-dimensional
CABG  coronary artery bypass graft
CAC  coronary artery calcifications
CAD  coronary artery disease
CCA  conventional coronary angiography
CT  computed tomography
EBA  electron-beam angiography
EBT  electron-beam tomography
ECG  electrocardiographic
HR  heart rate
MDCT  multi-row-detector spiral computed
tomography
MRA  magnetic resonance angiography
MRI  magnetic resonance imaging
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acquisition during the slow portion of coronary motion
(diastole) (20,21). Contrast-enhanced electron beam an-
giography (EBA) is an emerging technology with the
potential for obtaining essentially noninvasive coronary
arteriograms (Figs. 1 and 2). Recent studies have reported
contrast-enhanced, ECG-triggered, 3D EBA for detecting
and grading coronary stenosis (22–28).
Coronary artery EBA, a noninvasive diagnostic procedure
for demonstrating coronary artery anatomy, was first intro-
duced in 1995 (22). Two studies (28,29) confirmed that
coronary EBA with 3D techniques could reveal the lumen
of long segments of the major coronary arteries with high
correlation to conventional selective CCA (r  0.83) (29).
In evaluating this modality, comparison to CCA was
performed so as to assess the accuracy in which it can detect
a significant stenosis (50% luminal diameter). This mo-
dality has been demonstrated to identify significant coronary
lumen narrowing (50% stenosis) with the sensitivity of
74% to 92%, specificity of 79% to 100%, and accuracy of
81.2% to 93.4% (Table 2). Summary data demonstrate an
overall sensitivity of 87% and specificity of 91% for the 583
patients reported in these studies. The EBT noninvasive
angiography had a success rate of 70% to 93% in the ability
to correctly interpret all three coronary arteries per patient
(26–28). Also, interobserver reproducibility was found to be
high (0.74 to 0.90 by Cohen’s kappa statistic) (26,27).
There is fair uniformity and imaging standards among
EBA studies. The imaging procedure used by the above
studies are all performed with similar imaging techniques.
The studies were performed with a C-100 or C-150XLP
electron beam CT scanner (Imatron, South San Francisco,
California). The ECG triggering is employed so that each
Table 1. Characteristics and Risk Ratio for Follow-Up Studies Using Electron Beam Tomography (Modified From Budoff [19])
Investigator No.
Mean Age
(yrs)
Follow-Up
Duration (yrs)
Gender
(% Male)
Calcium Score
Cutoff Risk Ratio
Georgiou 192 53 4.2 54 Median† 13.1
Detrano 491 57 2.5 64 Top quartile 10.8
Keelan 288 56 6.9 77 Median (480) 3.2
Arad 1,173 53 3.6 71 CAC 160 20.2
Agatston 367 52 6.0 68 CAC 50 16.9
Detrano 1,196 66 3.4 89 CAC 44 2.3
Park (subset of Detrano) 967 67 6.4 91 CAC 142.1 4.9
Raggi 632 52 2.7 51 Top quintile* 15.4
Wong 926 54 3.3 79 270-top quartile 8.8
Arad 5,585 59 4.3 70 CAC 100 10.7
Kondos 5,635 51 3.1 74 CAC present men 10.5, women 2.6
*Using age- and gender-matched cohorts, representing the top quintile; †using age- and gender-matched cohorts, representing top quartile.
CAC  Coronary Artery Calcium Score.
Figure 1. Electron-beam angiogram (left) and corresponding invasive angiograms (right) of a person referred to the cardiac catheterization laboratory for
evaluation of chest pain. The three-dimensional reconstruction and corresponding angiograms revealed no significant obstructive disease, but did reveal 20%
to 30% stenosis of right coronary artery in the midvessel (black arrow).
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image is obtained at the same point in diastole. Iodinated
contrast is administered through an antecubital or jugular
vein with an injection rate of 4 ml/s and total volume of 120
to 160 ml. Forty to 50 images are obtained over a single
breath-hold, usually over 25 to 40 s. This entire protocol is
performed within 15 min. The test is easy to perform, and
interpretation can be made in minutes.
Limitations of EBT. The EBA studies had a technical
success rate of 85% to 100%, and 8% to 25% of coronary
arteries were nonassessable (Table 2). Impaired image qual-
ity, due to multiple image artifacts including coronary artery
motion and breathing artifacts, limited EBA clinical use.
One major limitation of all noninvasive imaging is dense
calcifications in the coronary tree, with investigators citing
scores 500 or 1,000 as problematic (26,27). Because the
calcification score is not always known in advance of
noninvasive angiography, some cases will prove nondiag-
nostic. In EBA studies, distal arteries are not as well
visualized as the proximal segments. This is most likely due
to the greater motion artifacts from cardiac pulsation and
the partial volume effect (due to small vessel diameters) in
distal epicardial vessels, as compared with the proximal
segments (24,26,30). Another limitation of all noninvasive
angiography is the relative inability to visualize collaterals.
The main determinant of false positive results for diagnos-
ing 50% coronary luminal stenosis was small vessel size
(22,30), and the diameter of stenotic segments tends to be
underestimated by EBA (24).
Some progress has been made over the last year to
improve image quality and interpretation of the EBA.
Recent studies revealed that the ECG triggering at 80% of
the R-R interval (late diastole) used in most earlier studies
might not be optimal for imaging of the coronary segments
near the right or left atria, because atrial contraction during
end-diastole causes rapid movement of the base of the heart
(26,31). It has been recently demonstrated that there is less
coronary motion at 40% of the R-R interval (early diastole
or end-systole) (32,33), which might significantly improve
imaging. Improvements including more reliable ECG gat-
ing, use of different ECG triggers (40% instead of 80% of
the R-R interval), and greater experience with this tech-
nique will continue to improve accuracy. Hardware im-
provements in the EBT scanner should also lead to higher
accuracy. An available high-resolution detector system im-
proves the spatial resolution by almost 40%, thus enabling
improved imaging performance for future studies (34).
Furthermore, the new e-speed scanner (GE-Imatron, South
San Francisco, California) allows for image acquisition in 50
ms, as well as obtaining dual imaging and allowing for
thinner slices with less cardiac motion. Currently, the high
negative predictive values (95% to 98%) have demonstrated
the ability of this tool to effectively “rule out” the presence of
obstructive CAD, thus helping the clinician to potentially
utilize this tool to determine the need for medical versus
revascularization therapy.
Electron beam angiography after revascularization. The
EBA is a promising tool in the follow-up after coronary
interventions, with the potential to replace some invasive
catheterization procedures (Figs. 3 to 5) (35). The utiliza-
tion of EBA to detect the patency of coronary artery bypass
graft (CABG) has been reported as early as 1986 (36).
Saphenous vein grafts, which are generally of large caliber
and have little cardiac motion, are especially well suited for
noninvasive imaging with EBA (Figs. 4 and 5). Flow studies
(sequential image acquisition to determine the rate of
contrast enhancement at a particular point in the anatomy)
demonstrate graft patency with sensitivities of 93% to 96%
and specificities of 86% to 100% (35,37–40). Using 3D
visualization in patients post-CABG, graft stenosis and
patency can be determined. Recent studies demonstrated a
sensitivity of 92% to 100% and specificity of 91% to 100%
for establishing patency (and lack of significant obstructive
disease) of saphenous vein grafts as compared with CCA
Figure 2. Electron-beam angiogram of the distal coronary arteries. Al-
though the distal right coronary can only be visualized 80% of the time by
this technique, this image demonstrates the posterolateral marginal branch
(PLMB) and posterior descending arteries (PDA). Image courtesy of Dr.
Beh, Kuala Lumpur, Malaysia.
Table 2. Comparisons of Contrast-Enhanced Electron Beam
Computed Tomography and Invasive Coronary Angiography
Investigator (Ref) Patients
Sensitivity
(%)
Specificity
(%)
Unevaluable
(%)
Achenbach (27) 125 92 94 25
Budoff (26) 52 78 91 11
Moshage (22) 20 74 100 —
Reddy (25) 23 88 79 8
Rensing (30) 37 77 94 19
Schmermund (31) 28 83 91 12
Nakanishi (111) 37 74 94 12
Moshage (100) 118 90 82 24
Achenbach (112) 36 92 91 20
Lu (113) 107 91 93 7
Summary 583 87 91 16
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(35,41,42). The same studies demonstrated sensitivity and
specificity for patency of left internal mammary of 80% to
100% and 82% to 100%, respectively. Studies by Achenbach
et al. (35) and Ha et al. (41) demonstrated that significant
stenoses can be determined by EBT in the grafts, similar to
those assessed in the native coronary arteries.
Percutaneous transluminal coronary angioplasty proce-
dures are performed worldwide as one of the main methods
for coronary artery stenosis treatment (43). However, even
with intracoronary stents, restenosis (closure) of the site of
angioplasty is still the greatest risk, which can lead to both
Figure 3. Electron-beam angiogram taken after symptoms of chest discomfort status postpercutaneous coronary angioplasty of the proximal left anterior
descending. The image reveals a restenosis (black arrows) of the left anterior artery on both noninvasive and invasive angiograms.
Figure 4. Electron-beam angiogram of a person eight years’ postcoronary
bypass surgery. The left internal mammary graft is widely patent, inserting
into the left anterior descending artery (black triangles). The distal artery
is well seen and patent, with minimal distal disease. There are two closed
saphenous vein grafts (black arrowheads), in addition to two patent
saphenous vein grafts, one to a diagonal and one to an obtuse marginal.
The right coronary artery has a 100% midvessel stenosis (black arrows).
Figure 5. Electron-beam angiogram of a person 22 years after coronary
bypass surgery. A saphenous vein graft is widely patent, inserting into the
left anterior descending artery, just after a high-grade stenosis in the native
coronary (white triangles). The distal artery is well seen and patent,
extending around the apex of the heart. Three saphenous vein grafts are
closed proximally (black arrowheads).
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MI and death. Chest pain after stenting or angioplasty often
requires visualization of the site of angioplasty to assess for
early closure. A noninvasive method to visualize the site of
angioplasty could potentially be used for less typical presen-
tations of acute closure (no typical angina or ECG changes
suggestive of ischemia). Use of EBA has been shown to
permit imaging of the coronary arteries and detection of
high-grade restenosis after coronary angioplasty (Fig. 3).
Achenbach et al. (44) reported 50 cases in which coronary
angioplasty was performed without coronary stent implan-
tation. The sensitivity and specificity of EBA was 94% and
82%, respectively, to detect severe stenosis (70% stenosis).
Intracoronary stenting is now increasingly used to de-
crease the restenosis rate of coronary angioplasty (45) and to
avoid emergent complications, such as acute thrombus,
coronary artery dissection, and even emergent CABG (46).
The ability to visualize the coronary lumen through the
metal of the stent poses severe problems for EBA, MDCT,
and magnetic resonance angiography (MRA). The wide-
spread utilization of metal stents during revascularization
procedures provides a major limitation for the clinical
application of these techniques. One potential solution to
the problem of visualizing the lumen within the stented
region is to utilize EBA flow studies to evaluate contrast
enhancement distal to the stent for patency (47–50). Pump
et al. (50) reported a sensitivity of 78% (18 of 23 stenoses
detected) and specificity of 98% (189 of 193 stents correctly
judged to be free of stenosis) for the detection of significant
in-stent restenosis by EBA flow measurements.
Current clinical uses. The most common clinical applica-
tion of EBA is to evaluate patients with symptoms post-
CABG surgery and coronary angioplasty evaluation, assess-
ment of congenital heart disease and coronary anomalies
(51), and measurement of wall motion, myocardial mass,
and right and left ejection fractions (52,53). Given the high
negative predictive values, use in patients with lower prob-
abilities of obstructive disease will potentially allow physi-
cians to exclude obstructive CAD in proximal and midves-
sels. As compared with CCA, use of EBA is minimally
invasive, has an extremely short acquisition time, and was a
markedly lower radiation dose (54). Patients unable to
breath-hold for 25 s, those with significant arrhythmias, and
morbidly obese patients are poor candidates for EBA. The
Food and Drug Administration has approved EBT for use
in noninvasive coronary angiography. The newest model of
EBT is the e-speed scanner, allowing for 50-ms image
acquisition and multidetector imaging. This new device,
currently available only in limited centers, will shorten
breath-hold, lower radiation, and decrease motion artifacts
owing to faster image acquisition.
SPIRAL COMPUTED TOMOGRAPHY
The “need for speed” is essential in obtaining virtually
motion-free images. The significantly improved temporal
and spatial resolution of MDCT scanners opens up new
possibilities for cardiac imaging. Because of high in-plane
resolution and thin-slice collimation (up to 1.0 mm),
high-quality images can be obtained (Fig. 6). However, as
the mechanical detector head must rotate around the pa-
tient, no current CT can obtain a full rotation in less than
400 ms, too slow to allow for motion-free imaging of the
coronary arteries (55,56). Multislice CT has the new capa-
bility of obtaining multiple images simultaneously, contin-
uously imaging, obtaining 4, 8, or even 16 slices at once.
Each slice is still obtained with the limited gantry rotation
speed, but simultaneous imaging allows for thinner slices
and shorter scanning protocols (decreased need for long
breath-holding by patient). The newer MDCT equipment
now rotates at 420 ms, with up to 16 detectors for cardiac
imaging.
Through the use of simultaneously recorded ECG data,
images from the MDCT can be reconstructed at any point
Figure 6. Multislice computed tomography angiogram (four-detector) of
the left anterior descending (L) and right coronary artery (R).
Table 3. Comparisons of Contrast-Enhanced Four-Level
Multirow Detector Spiral Computed Tomography and Invasive
Coronary Angiography
Investigator (Ref) Patients
Sensitivity
(%)
Specificity
(%)
Unevaluable
(%)
Achenbach (59) 64 85 76 32
Knez (58) 44 58 91 30
Hong (114) 25 80 76
Giesler (115) 83 56 86 29
Giesler (60) 100 49 89 29
Nieman (61) 53 61 93 30
Nieman (62) 78 63 94 32
Kuettner (63) 66 37 99 31
Summary 513 59 89 31
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in the cardiac cycle. The MDCT obtains continuous volume
imaging of the heart (up to 400 images of the coronary tree
are obtained), then utilizes a fraction of the obtained data
for image reconstruction. Retrospective triggering, acquir-
ing partial data on each scan, may allow shorter acquisition
times, but require sophisticated postprocessing algorithms
to reduce motion artifacts (56). Several studies are listed in
Table 3. Achenbach et al. (57) reported the applicability and
image quality of MDCT and EBT on 30 patients without
coronary stenoses. This demonstrated that coronary arteries
could be visualized over long segments. On average, 73% of
the proximal and midsegments could be visualized free of
motion artifacts with MDCT (92% with EBT, p  0.001),
and coronary diameters showed close correlation with both
techniques to quantitative coronary angiography (r  0.86).
Multiple studies with four-slice MDCT have been re-
ported. Most studies reported a diminished overall sensitiv-
ity. One MDCT study demonstrated an overall sensitivity
of 58%, which varied widely from vessel to vessel (58). The
left main coronary artery had a sensitivity of 100%, whereas
stenoses in the circumflex had a sensitivity of only 44%.
Most studies demonstrate approximately 70% of vessels
available for analysis (Table 2). Another study had 68% of
vessels interpretable, and 32 of 58 high-grade stenoses were
detected (sensitivity 58%) (59). However, all four major
coronary arteries could be evaluated in only 30% of patients.
The investigators note that “its clinical use may presently be
limited due to degraded image quality in a substantial
number of cases, mainly due to rapid coronary motion.”
Giesler et al. (60) reported 115 of 400 (29%) coronary
arteries uninterpretable, and in only 39% of patients were all
coronary arteries assessable by MDCT. Overall, 51 (49%) of
104 stenoses were revealed on MDCT. Most studies dem-
onstrate a significant heart rate (HR) interaction. One study
showed that overall sensitivity for stenosis detection de-
creased from 62% (HR 70 beats/min) to 33% (HR 70
beats/min) (60), whereas sensitivity dropped in another
study from 82% (mean HR 55.8 beats/min) to 32% (mean
HR 81.7 beats/min) (61,62). In another study (63), the
correct clinical diagnosis could be obtained in only 36% of
patients (Table 3).
Limitations of MDCT. Because radiation is continuously
applied while only a fraction of the acquired data is utilized,
high radiation doses (doses of 6 to 10 mSv/study) limit the
clinical applicability of this modality (54,64). In female
patients, the effective radiation dose is another 25% higher
than in male patients (WinDose 2.0a, Scanditronix Well-
hofer, Bartlett, Tennessee), raising the mean dose from 8
mSv in men to 10 mSv per study in women (65). These
radiation doses are two to five times higher than can be
expected for conventional angiography, and 5- to 10-fold
higher than doses obtained during EBA (1 to 1.7 mSv)
(2,64,67). In two studies of radiation dose, EBA yielded
doses of 1.5 to 2.0 mSv, MDCT angiography 8.1 to 13
mSv, and coronary angiography 2.1 to 2.3 mSv (66),
whereas another study reported EBA doses of 1.1 mSv and
MDCT doses of 9.3 to 11.3 mSv (67). The radiation dose
using the new 16-level detectors has not yet been reported.
Current clinical uses. The use of the new 16-slice MDCT
scanners (420-ms rotation time, 12 0.75 mm collimation)
allows for faster and thinner imaging than the four-slice
scanners. Two studies have been reported, each with im-
proved accuracy as compared with prior reports with four-
slice scanners. These studies reported sensitivity of 73% to
95% and specificity of 86% to 93% (68,69). Both studies
concluded the MDCT with beta-blocker premedication
permits detection of CAD with high accuracy. Reduced
radiation doses and improved rotation times will make
MDCT a more clinically useful modality.
Figure 7. Navigator-echo–based, noncontrast-enhanced magnetic reso-
nance coronary angiography (A) in a patient with a stenosis of the left
anterior descending coronary artery (arrows). (B) Corresponding invasive
coronary angiogram of that patient.
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Magnetic resonance angiography. The MRA provides
excellent soft tissue contrast, has inherent 3D capabilities,
and allows acquisition in any anatomic plane. Furthermore,
MRA does not expose the patient to radiation, nor iodin-
ated contrast, making this the safest of the current nonin-
vasive modalities, excluding those patients with pacemakers,
implantable defibrillators, or recent stent placement. An
MRA of the coronary arteries became possible in 1991 with
the development of a new group of fast magnetic resonance
imaging (MRI) sequences (70,71). The new MRI tech-
niques may also allow quantification of velocity and flow in
coronary arteries; also, MRI has proved successful in pro-
ducing angiograms of peripheral vascular anatomy and
abnormalities (72). Recent advances in fast magnetic reso-
nance imaging (MRI) have allowed for compensation of
coronary and respiratory motion (73–76). However, limita-
tions in spatial and temporal resolution make visualizing
coronary artery lumens more difficult (Fig. 7–9).
All coronary MRA techniques use ECG-triggering.
First-generation breath-hold techniques acquire one two-
dimensional image per breath-hold; however, the clinical
usefulness was severely limited (77–82). The second-
generation techniques use respiratory gating or triggering
and are referred to as “non-breath-holding” or “free-
breathing” techniques, as they do not require breath-
holding during image acquisition (83,84). Third-generation
techniques that allow 3D volume acquisitions in a single
breath-hold, in combination with real-time interactive slice
positioning, appear very promising. Real-time slice posi-
tioning, and higher-resolution acquisition schemes, such as
spiral MRA, can further improve and facilitate the use of
these coronary MRA techniques (85–96) (Figs. 7 and 8).
The newest versions will allow 3D volume acquisitions in
one breath-hold and/or real-time interactive slice position-
ing (Fig. 9) (97–101). In addition, the use of magnetic
resonance contrast agents appears to further improve some
techniques (102,103).
TWO-DIMENSIONAL MAGNETIC RESONANCE CORONARY
ANGIOGRAPHY (FIRST- AND SECOND-GENERATION TECH-
NIQUES). The breath-hold two-dimensional technique rep-
resented the first attempt at high-resolution imaging of the
coronary arteries (77). A breath-hold lasting 16 heartbeats
could produce a single image (Table 4). However, multiple
breath-holds were necessary to cover all parts of the coro-
nary artery tree, and the exact reproduction of the level of
inspiration required extremely good collaboration of the
patient and caused problems in up to 44% of all subjects.
Other limitations of the technique included long study
times, difficulties in distinguishing veins or pericardial
structures from coronary arteries, poor visualization of the
left main coronary artery, and impaired image quality due to
Figure 8. Three-dimensional surface reconstruction of normal coronary
arteries obtained by navigator-echo–based three-dimensional magnetic
resonance coronary angiography.
Figure 9. Magnetic resonance coronary angiogram of the right coronary
artery obtained in a single breath-hold. A stenosis of the right coronary
artery can be seen (arrow, A). (B) Corresponding invasive coronary
angiogram also demonstrates the stenosis.
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ghosting, ringing, and blurring (79). Although an early
study with MRA yielded favorable results (78), multiple
subsequent studies could not reproduce the promising results
obtained in these initial reports (73,79–82) (Table 4).
THE 3D RESPIRATORY GATED MAGNETIC RESONANCE COR-
ONARY ANGIOGRAPHY TECHNIQUES (THIRD-GENERATION
TECHNIQUES). A number of clinical studies have compared
the results obtained by these 3D respiratory-gated MR
coronary angiography techniques to conventional invasive
coronary angiography (Figs. 7 and 8) (90–93). Accuracy
varies widely from study to study (sensitivity: 38% to 83%,
specificity: 57% to 95%) even when the exams of subjects
with poor image quality are excluded (Table 4). A recent
multicenter study of 109 patients using the free-breathing
technique revealed a total of 636 of 759 proximal and
middle segments of coronary arteries (84%) were interpret-
able on MRA (104). In these segments, 78 (83%) of 94
clinically significant lesions (those with a 50% reduction)
were detected by MRA. Overall, coronary MRA had an
accuracy of 72% (95% confidence interval, 63% to 81%) in
diagnosing CAD (104). Summary data reveal a sensitivity of
77% and specificity of 71% in the 387 patients reported in
these studies.
Study limitations. The combination of temporal and spa-
tial resolution currently available with MRA is limited. For
MRA, the spatial resolution is inversely proportional to the
temporal resolution. Currently used protocols use temporal
resolution of approximately 125 ms, and spatial resolution of
1.2  1.2  2.0 mm (Table 5). Other limitations are due to
calcifications, metal artifacts, thickened pericardium, and
pericardial fluid collections, as well as a mean study time of
70 min (42,104). Finally, patients with claustrophobia,
recently implanted stents or other metallic objects, pace-
makers, or implantable defibrillators cannot undergo this
procedure.
RECENT DEVELOPMENTS. To overcome the difficulties as-
sociated even with 3D navigator-echo–based image acqui-
sition techniques for coronary MRA, a number of new
imaging protocols have been developed. Major aim of these
approaches was to increase the signal-to-noise ratio of the
coronary artery through the injection of contrast agent (Fig.
8) (99,101–106). By use of flow modes and 3D reconstruc-
tion, MRI can also visualize CABG patency with high
accuracy. Studies demonstrate a diagnostic sensitivity of
93% to 98% and specificity of 85% to 97% for saphenous
vein grafts (107,108).
Clinical applications. Although the role of coronary artery
MRA for stenosis detection has not yet been established,
coronary MRA has already been very successful in the
detection of coronary artery variants, and the imaging of
coronary stents and bypass grafts (109,110). Spatial and
temporal resolution are constantly improving and, in se-
lected cases under nonclinical conditions, MR even permits
imaging of the coronary vessel wall (75). Multiple new
techniques (including new coils, contrast agents, and acqui-
sition methodology) are currently being developed and
should continue to improve upon the current state.
Conclusions. Electron beam angiography (111–113),
MDCT (68,114,115), and MRI coronary angiography
(116,117) are rapidly developing techniques and currently
Table 4. Sensitivity and Specificity for the Detection of Coronary Artery Stenoses by Two-
Dimensional Breath-Hold (First Generation) Magnetic Resonance Coronary Angiography in
Comparison With Conventional Invasive Coronary Angiography
Investigator (Ref) Patients
Sensitivity
(%)
Specificity
(%)
Spatial
Resolution (mm)
Temporal
Resolution (ms)
Manning (78) 39 90 92 1.4  0.9  5.0 80–104
Pennell (80) 39 85 – 1.6  0.8  5.0 126
Post (81) 35 40–63 89–97 1.8  1.0  4.0 88–113
Mohiaddin (82) 16 56 82 1.6  0.8  4.0 126
Duerinckx (73) 21 63 – 1.0  2.0  5.0 117
Table 5. Detection of Coronary Artery Stenoses: Comparison of the Sensitivity and Specificity
(50% Stenosis) of Third-Generation Magnetic Resonance Coronary Angiography With
Conventional Invasive Coronary Angiography
Investigator (Ref) Patients
Sensitivity
(%)
Specificity
(%)
Spatial
Resolution (mm)
Temporal
Resolution (ms)
Post (90) 20 38 95 1.2  2.3  2.1 260
Woodard (91) 10 70 – 1.2  2.0  3.0 –
Kessler (92) 73 65 88 1.2  1.2  2.0 125
Mu¨ller (93) 30 83 94 1.2  1.2  2.0 125
Sandstede (94) 30 81 89 1.2  1.2  2.0 230
van Geuns (117) 27 54 91 1.95  1.25  2.0 –
Regenfus (116) 50 94 57 1.4  1.25  1.5 294
van Geuns (101) 38 68 97 1.9  1.25  1.5 –
Kim (104) 109 93 42
Total 387 77 71 – –
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not an alternative to conventional CCA in all cases (Table
6). All three, however, are currently used clinically in certain
centers. Selective use might prove both cost-effective and
provide a safer, less-invasive method for patients. These
noninvasive techniques have potential capabilities of assess-
ing perfusion and coronary flow in addition to coronary
anatomy, and thus may provide a comprehensive cardiac
evaluation.
Successful development of a noninvasive angiogram with
consistently high sensitivity and specificity for obstructive
CAD would greatly reduce the cost and also the morbidity
and mortality currently associated with conventional coro-
nary arteriography. The replacement of some of these
invasive procedures by noninvasive means would be very
desirable. Some potential uses include: following the non-
diagnostic stress test; for those persons with intermediate
likelihood of CAD (where the step to coronary angiography
might be premature); for symptomatic persons postcoronary
angioplasty and possibly post-stent; evaluating graft patency
post-CABG, and for early detection of obstructive CAD in
the high-risk individual. Given the current utility of these
techniques, we can expect a rapid growth in both the
knowledge and experience with noninvasive angiography,
leading to a much wider clinical use of these new techniques
in visualizing the coronary lumens to evaluate obstructive
coronary disease.
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